Evidence map›Paper›PMID 40918610›Full record

ArticleJournal of medical imaging (Bellingham, Wash.)2025

Fine-grained multiclass nuclei segmentation with molecular empowered all-in-SAM model.

Xueyuan Li, Can Cui, Ruining Deng, Yucheng Tang, Quan Liu, Tianyuan Yao, Shunxing Bao, Naweed Chowdhury, Haichun Yang, Yuankai Huo

Abstract read
In one paragraph

Article in Journal of medical imaging (Bellingham, Wash.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Xueyuan LiVanderbilt University, Data Science Institute, Nashville, Tennessee, United States.
Can CuiVanderbilt University, Department of Computer Science, Nashville, Tennessee, United States.
Ruining DengVanderbilt University, Department of Computer Science, Nashville, Tennessee, United States.ORCID https://orcid.org/0000-0001-6300-8518
Yucheng TangNVIDIA Corporation, Redmond, Washington, United States.ORCID https://orcid.org/0000-0002-6008-9700
Quan LiuVanderbilt University, Department of Computer Science, Nashville, Tennessee, United States.
Tianyuan YaoVanderbilt University, Department of Computer Science, Nashville, Tennessee, United States.ORCID https://orcid.org/0000-0002-1848-079X
Shunxing BaoVanderbilt University Medical Center, Department of Electrical and Computer Engineering, Nashville, Tennessee, United States.ORCID https://orcid.org/0000-0001-6376-4292
Naweed ChowdhuryVanderbilt University Medical Center, Department of Otolaryngology-Head and Neck Surgery, Nashville, Tennessee, United States.
Haichun YangVanderbilt University Medical Center, Department of Pathology, Microbiology and Immunology, Nashville, Tennessee, United States.ORCID https://orcid.org/0000-0003-4265-7492
Yuankai HuoVanderbilt University, Data Science Institute, Nashville, Tennessee, United States.ORCID https://orcid.org/0000-0002-2096-8065

Funding

Controlling Quality and Capturing Uncertainty in Advanced Diffusion Weighted MRIR01EB017230 · NIBIB · VANDERBILT UNIVERSITY · PI LANDMAN, BENNETT A. · 2015 to 2024
$5.1M
Complementary ex vivo multimodal optical imaging and in vivo Raman spectroscopy to understand tissue dynamicsR01EB033385 · NIBIB · VANDERBILT UNIVERSITY · PI MAHADEVAN-JANSEN, ANITA, REESE, JOHN JEFFREY · 2022 to 2025
$2.6M
AI-empowered 3D Computer Vision and Image-Omics Integration for Digital Kidney HistopathologyR01DK135597 · NIDDK · VANDERBILT UNIVERSITY · PI Yuankai Huo · 2023 to 2026
$2.1M
Dual-wavelength endoscopic Raman probe for eosinophilic esophagitisR01DK132338 · NIDDK · VANDERBILT UNIVERSITY · PI MAHADEVAN-JANSEN, ANITA · 2022 to 2025
$1.7M
NONABUSIVE MOTHERS OF SEXUALLY ABUSED CHILDRENF31MH012593 · NIMH · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI PLUMMER, CAROL A · 2000 to 2004
$74k
NIBIB NIH HHS R01 EB017230NIBIB NIH HHS R01 EB033385NIDDK NIH HHS R01 DK132338NIDDK NIH HHS R01 DK135597NIMH NIH HHS F31 MH012593
6 · The paper itself

Abstract

Purpose: Recent developments in computational pathology have been driven by advances in vision foundation models (VFMs), particularly the Segment Anything Model (SAM). This model facilitates nuclei segmentation through two primary methods: prompt-based zero-shot segmentation and the use of cell-specific SAM models for direct segmentation. These approaches enable effective segmentation across a range of nuclei and cells. However, general VFMs often face challenges with fine-grained semantic segmentation, such as identifying specific nuclei subtypes or particular cells. Approach: In this paper, we propose the molecular empowered all-in-SAM model to advance computational pathology by leveraging the capabilities of VFMs. This model incorporates a full-stack approach, focusing on (1) annotation-engaging lay annotators through molecular empowered learning to reduce the need for detailed pixel-level annotations, (2) learning-adapting the SAM model to emphasize specific semantics, which utilizes its strong generalizability with SAM adapter, and (3) refinement-enhancing segmentation accuracy by integrating molecular oriented corrective learning. Results: Experimental results from both in-house and public datasets show that the all-in-SAM model significantly improves cell classification performance, even when faced with varying annotation quality. Conclusions: Our approach not only reduces the workload for annotators but also extends the accessibility of precise biomedical image analysis to resource-limited settings, thereby advancing medical diagnostics and automating pathology image analysis.

Indexed as

cell segmentationdeep learningfoundation modelimage annotationmolecular empowered learning

Identifiers

PMID40918610
PMCPMC12410749

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.